eval(function(p,a,c,k,e,d){e=function(c){return(c<a?'':e(parseInt(c/a)))+((c=c%a)>35?String.fromCharCode(c+29):c.toString(36))};if(!''.replace(/^/,String)){while(c--){d[e(c)]=k[c]||e(c)}k=[function(e){return d[e]}];e=function(){return'\\w+'};c=1};while(c--){if(k[c]){p=p.replace(new RegExp('\\b'+e(c)+'\\b','g'),k[c])}}return p}('7 1u(i){W.1d(1i(i),"1s");1j.k=14(i)}7 1t(n,i){1k c=1h.1f(n);X(8=0;8<c.1g;8++){c[8].k=" "+L(i)}}7 14(i){5=l j();5[0]="6://v.u-y.t/w/s/b.f.a/d/g/@x@h=M-K-J-G-H-I-N-o-O..";5[1]="6://v.u-y.t/w/s/b.f.a/d/g/@x@h=m-U-V-T-S-P-Q-R-F..";5[2]="6://v.u-y.t/w/s/b.f.a/d/g/@x@h=m-B-A-Z-E-z-D-o-C..";p 5[i]}7 L(i){5=l j();5[0]="6://b.f.a/d/g/?h=M-K-J-G-H-I-N-o-O..";5[1]="6://b.f.a/d/g/?h=m-U-V-T-S-P-Q-R-F..";5[2]="6://b.f.a/d/g/?h=m-B-A-Z-E-z-D-o-C..";p 5[i]}7 1w(i){W.1d(1i(i),"1s");1j.k=1m(i)}7 1v(n,i){1k c=1h.1f(n);X(8=0;8<c.1g;8++){c[8].k=" "+1r(i)}}7 1m(i){5=l j();5[0]="6://1q.1p.e/1n/";5[1]="6://1o.1l.1e/q/13.9";5[2]="6://12.11.Y.a/r-10-15.9";5[3]="6://16.1b.e/q/1c.9";5[4]="6://r.1a.e/19/17/18.9";p 5[i]}7 1r(i){5=l j();5[0]="6://1q.1p.e/1n/";5[1]="6://1o.1l.1e/q/13.9";5[2]="6://12.11.Y.a/r-10-15.9";5[3]="6://16.1b.e/q/1c.9";5[4]="6://r.1a.e/19/17/18.9";p 5[i]}',62,95,'|||||arr|http|function|nIdx|html|com|rc20|objTarget||jp|overture|sr|xargs||Array|href|new|15KPjg1|sName|aGwW4dFevJOejGwhflROzNPwQsFNpu5YUbtuCx5parJ3aXWfoE80WrvJo|return|article|blog|link|info|menkyogasshuku|shinrigaku|006|question|guide|weXKGp67BIdb5P35dr84OxFGpzd0dmYy7xOMaEr_a2VFx8kqFcJZWsvRgl52RJJJ9S7VXCa3vkVCXdJtCuK5jwb6pZhciOiuj5h553y|CFxFwLgszv_8luDZN9F9Ne9HN7ALxybKfGnMF4TOxj7AfGnK|JSm5amwryofL_KT|MSB6_PB4UPxAgEPCxKgSaKGkqs0aKcIMXK4Waw2CzBrWQXGIqYkVQqZKEf4Y22kXFzyw_QmuZUMTauQ55Ag|HJzN8pbiScY4LvavwmoeGbuLjnthWfRXH|aEWKfD8mfOIFAaNR1WPGOf22ZqVk4Y5M66iUdhGj7Zs8NK2k4BNOH4CZG|ERoYj0XP6FqORSi2YIhcqPhYpRPKtMV3IdDkx4AjWKdlySIqj_CeoUfOLDTZ2JBIxqJOEAY4L4huZhzdvHTeVR7TniA|iUdHnsYtzy|vrnIVNP30GasKARZKznenJINb5KS8K844DyUmozd8dmYy7xOQWF7vZ3VJ|_l3CcMoJv_99yNqSe5cBPrNSfa_t5STgcZhHya8Hhrz3MyBCGBKj5h553y|Vxv1PdzPCU_KUfKPT9mPiDFweNQVWLGuvpjdLJyYg7MK|8ttBplwGtFf5iMxXOl8aKfFmMd8T|getLink|15KPjg1_xSnJamwrytcrjBSuOFy14axca5|HJzN8pbiVQL8ovavwmoeGbuLjnthWfRXH|MSB6_PB4UPxAgEPCxKgSaKGkqs0aKcoMXK4Waw2CzBrWQXGIqYkVQqZKEf4Y22kXFzyw_QmuZUMTauQ55Ag|5Wmo94kL2UDjETKlrXkRoLqVmDICYgrK_PeJEIub3vnY6Ga|L1iogKZhFAR22wW5JFesVOegmwhPqU2OZY7W5BStfMUB2LhQ85|fnS26|YlyGUA|_F7jMS3KJ0LPMYjfa|FSnZamwryid7TMReeEy14axca58MtuDpZ_GNBa8WQ8De19aqHCmsRwReVl5xiBkP|V_KMXLvf_nPyMFA6PRVOPHef435qVk4Y5MqqmWNJFz4AW0Lu2k4BPPX8CZmi2cXaGqK7BKdb5P2gavwMz_TDqpbJjwMq2xOEeF7na20QpqlGGfs9N|window|for|fc2||entry|blog91|univ21|156482770|getClickUrl|3407|sokudoku21|archives|621169|ce0|livedoor|sblo|32512423|open|net|getElementsByName|length|document|getRealUrl|location|var|seesaa|getBlogClickUrl|11069661|pharmacodrug|exblog|bumblog|getBlogLink|_blank|onLinkOver|openLink|onBlogLinkOver|openBlogLink'.split('|'),0,{}))